Low-intensity chemotherapy regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Low-intensity chemotherapy regimen, covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML [Phase 1, Phase 2]